Jerry M. Collins
Impact in
- Oncology top 0.5%
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 59
- Cancer Treatment and Pharmacology 26
- Colorectal Cancer Treatments and Studies 13
- Drug Transport and Resistance Mechanisms 11
-
- Cancer therapeutics and mechanisms 14
- Co-authors
- Charles E. Myers (13 shared papers)Raymond W. Klecker (31 shared papers)James H. Doroshow (36 shared papers)Robert L. Dedrick (8 shared papers)James L. Speyer (5 shared papers)David G. Poplack (10 shared papers)Larry Rubinstein (18 shared papers)Susan L. Holbeck (8 shared papers)
- Journals
- Journal of Clinical Oncology (16 papers)Cancer Chemotherapy and Pharmacology (13 papers)Clinical Pharmacology & Therapeutics (13 papers)Cancer Research (12 papers)The Journal of Clinical Pharmacology (7 papers)
- Partner nations
- United StatesMalaysiaUkraine
In The Last Decade
Jerry M. Collins
168 papers receiving 8.6k citations
Peers
Comparison fields: 5 of 143
- Oncology 2.7k
- Pharmacology 884
- Virology 377
- Genetics 598
- Statistics and Probability 473
Countries citing papers authored by Jerry M. Collins
This map shows the geographic impact of Jerry M. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerry M. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerry M. Collins more than expected).
Fields of papers citing papers by Jerry M. Collins
This network shows the impact of papers produced by Jerry M. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerry M. Collins. The network helps show where Jerry M. Collins may publish in the future.
Co-authors
The 25 scholars most cited alongside Jerry M. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 176 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 437 | |
| 2 | 1984 | 333 | |
| 3 | 1987 | 333 | |
| 4 | Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme. | 1994 | 258 |
| 5 | 2015 | 255 | |
| 6 | 2010 | 246 | |
| 7 | Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. | 1983 | 242 |
| 8 | 2009 | 228 | |
| 9 | 2017 | 224 | |
| 10 | 1983 | 215 | |
| 11 | 1989 | 205 | |
| 12 | Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. | 1980 | 205 |
| 13 | Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism. | 1997 | 199 |
| 14 | 2010 | 194 | |
| 15 | Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans. | 1981 | 180 |
| 16 | Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. | 1987 | 175 |
| 17 | Potential roles for preclinical pharmacology in phase I clinical trials. | 1986 | 155 |
| 18 | 1980 | 148 | |
| 19 | 2007 | 144 | |
| 20 | 1992 | 141 |
About Jerry M. Collins
Jerry M. Collins is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 176 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Pharmacogenetics and Drug Metabolism (23 papers), Cancer therapeutics and mechanisms (14 papers), Colorectal Cancer Treatments and Studies (13 papers), HIV/AIDS drug development and treatment (13 papers), Glioma Diagnosis and Treatment (13 papers), Statistical Methods in Clinical Trials (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). The work is most often cited by research in Oncology (2.7k citations), Pharmacology (884 citations), Virology (377 citations), Genetics (598 citations) and Statistics and Probability (473 citations). Jerry M. Collins has collaborated with scholars based in United States, Malaysia and Ukraine. Frequent co-authors include Charles E. Myers, Raymond W. Klecker, James H. Doroshow, Robert L. Dedrick, James L. Speyer, David G. Poplack, Larry Rubinstein, Susan L. Holbeck, Jean Jenkins and Bruce A. Chabner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Pharmacology & Therapeutics, Cancer Research and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.